Zhibing Ai
Zhibing Ai publishes mostly in Epidemiology, Neurology and Pulmonary and Respiratory Medicine, on topics such as Acute Ischemic Stroke Management, Intracerebral and Subarachnoid Hemorrhage Research and Cerebrovascular and Carotid Artery Diseases.
- World rank
- #1,368,461 of 7,710,434 ranked researchers
- Rank in China
- #201,723 of 978,568
- Works
- 21
- Citations
- 1.4k
- Citations per work
- 68.3
What does Zhibing Ai research?
Zhibing Ai's work is mostly in Medicine (39%), Biochemistry, Genetics and Molecular Biology (12%), Neuroscience (7%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else942.3%
- Health Sciences839.0%
- Medicine839.0%
- Life Sciences418.7%
- 1Epidemiology20% of their works
- 2Neurology10% of their works
- 3Pulmonary and Respiratory Medicine8% of their works
- 4Neurology7% of their works
- 5Molecular Biology7% of their works
- 6Cancer Research5% of their works
Research topics
- Acute Ischemic Stroke Management
- Intracerebral and Subarachnoid Hemorrhage Research
- Cerebrovascular and Carotid Artery Diseases
- Stroke Rehabilitation and Recovery
- Neuroinflammation and Neurodegeneration Mechanisms
- Neurological Disease Mechanisms and Treatments
- Venous Thromboembolism Diagnosis and Management
- COVID-19 and healthcare impacts
Which keywords describe Zhibing Ai's research?
The keywords of their largest research topics: Ischemic Stroke, Risk Factors, Endovascular Therapy, Thrombolysis, Neuroinflammation, Cerebral Amyloid Angiopathy, Intracerebral Hemorrhage and Carotid Artery Stenosis.
- Vascular Cognitive Impairment
- Microglia
- Cancer
- Antithrombotic Therapy
- Motor Recovery
- Carotid Artery Stenosis
- Cerebral Amyloid Angiopathy
- Thrombolysis
- Risk Factors
- Ischemic Stroke
- Endovascular Therapy
- Neuroinflammation
- Intracerebral Hemorrhage
- Endarterectomy
- Neural Plasticity
- COVID-19
- Cerebral Hypoperfusion
- Neurodegeneration
- Venous Thromboembolism
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 19 words, with their numbers
- Ischemic Stroke132 topics
- Risk Factors132 topics
- Endovascular Therapy111 topic
- Thrombolysis111 topic
- Neuroinflammation72 topics
- Cerebral Amyloid Angiopathy51 topic
- Intracerebral Hemorrhage51 topic
- Carotid Artery Stenosis41 topic
- Endarterectomy41 topic
- Motor Recovery31 topic
- Neural Plasticity31 topic
- Antithrombotic Therapy21 topic
- COVID-1921 topic
- Cancer21 topic
- Cerebral Hypoperfusion21 topic
- Microglia21 topic
- Neurodegeneration21 topic
- Vascular Cognitive Impairment21 topic
- Venous Thromboembolism21 topic
Where does Zhibing Ai work?
Zhibing Ai's main affiliation in the publication record is Hubei University of Medicine, China.
How many publications and citations does Zhibing Ai have?
OpenAlex counts 21 works and 1,434 citations for Zhibing Ai, an h-index of 11, ranking #1,368,461 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Zhibing Ai. Posts are plain text and can be reported.